Targeted management of severe asthma: Developing a Canadian approach

References

• Haahtela T , Järvinen M , Kava T , et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med . 1991;325(6):388–392. doi:https://doi.org/10.1056/NEJM199108083250603.
   PubMed Web of Science ®Google Scholar
• Government of Canada . Asthma and Chronic Obstructive Pulmonary Disease (COPD) in Canada, 2018. Report from the Canadian Chronic Disease Surveillance System http://www.canada.ca/en/public-health/services/publications/diseases-conditions/asthma-chronic-obstructive-pulmonary-disease-canada-2018.html. Published May 1, 2018. Accessed November 11, 2018.
   Google Scholar
• Wijesinghe M , Weatherall M , Perrin K , et al. International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance. Chest . 2009;135(4):1045–1049. doi:https://doi.org/10.1378/chest.08-2082.
   PubMedGoogle Scholar
• Chapman KR , Boulet LP , Rea RM , et al. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31(2):320–325. doi:https://doi.org/10.1183/09031936.00039707.
   PubMed Web of Science ®Google Scholar
• Chapman KR , Verbeek PR , White JG , et al. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med . 1991;324(12):788–794. doi:https://doi.org/10.1056/NEJM199103213241202.
   PubMed Web of Science ®Google Scholar
• FitzGerald JM , Lemiere C , Lougheed MD , et al. Recognition and management of severe asthma: A Canadian Thoracic Society position statement. Am J Respir Crit Care Med. 2017;1 :199–221. doi:https://doi.org/10.1080/24745332.2017.1395250.
   Google Scholar
• Bahadori K , Doyle-Waters MM , Marra C , Lynd L , et al. Economic burden of asthma: a systematic review. BMC Pulm Med . 2009;9(1):24. doi:https://doi.org/10.1186/1471-2466-9-24.
   PubMedGoogle Scholar
• Israel E , Reddel HK . Severe and difficult-to-treat asthma in adults. N Engl J Med . 2017;377(10):965–976. doi:https://doi.org/10.1056/NEJMra1608969.
   PubMed Web of Science ®Google Scholar
• Lougheed MD , Lemière C , Dell SD , et al. Canadian Thoracic Society Asthma Management Continuum ― 2010 Consensus Summary for children six years of age and over, and adults. Can Respir J. 2010;17(1):15–24. doi:https://doi.org/10.1155/2010/827281.
   PubMed Web of Science ®Google Scholar
• Husereau D , Goodfield J , Leigh R , et al. Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data. Allergy Asthma Clin Immunol . 2018;14(1):15. doi:https://doi.org/10.1186/s13223-018-0241-1.
   Google Scholar
• Foster JM , McDonald VM , Guo M , et al. I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J . 2017;50(3):1700765. doi:https://doi.org/10.1183/13993003.00765-2017.
   PubMed Web of Science ®Google Scholar
• Asthma Society of Canada. Severe Asthma : The Canadian Patient Journey. https://www.asthma.ca/wp-content/uploads/2017/06/SAstudy.pdf. Published 2017. Accessed September 28, 2018.
   Google Scholar
• Sadatsafavi M , Rousseau R , Chen W , et al. The preventable burden of productivity loss due to suboptimal asthma control: a population-based study. Chest . 2014;145(4):787–793. doi:https://doi.org/10.1378/chest.13-1619.
   PubMed Web of Science ®Google Scholar
• Bloechliger M , Reinau D , Spoendlin J , et al. Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis. Respir Res . 2018;19(1):75. doi:https://doi.org/10.1186/s12931-018-0742-y.
   PubMed Web of Science ®Google Scholar
• Sullivan PW , Ghushchyan VH , Globe G , et al. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116.e7. doi:https://doi.org/10.1016/j.jaci.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Luskin AT , Antonova EN , Broder MS , Chang EY , et al. Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis. CEOR. . 2016;Volume 8:641–648. doi:https://doi.org/10.2147/CEOR.S115025.
   Google Scholar
• Government of Canada . Product monograph: Pr-XOLAIR® (omalizumab). https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74602. Published 2017. Accessed October 1, 2018.
   Google Scholar
• Government of Canada . Product monograph: Pr-NUCALA (mepolizumab). https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93562. Published 2018. Accessed October 1, 2018.
   Google Scholar
• Government of Canada . Product monograph: Pr-CINQAIR-TM (reslizumab). https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94330. Published 2017. Accessed October 1, 2018.
   Google Scholar
• Government of Canada . Product monograph: Pr-FASENRA® (benralizumab). https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96262. Published 2018. Accessed October 1, 2018.
   Google Scholar
• Pepper AN , Renz H , Casale TB , et al. Biologic therapy and novel molecular targets of severe asthma. J Allergy Clin Immunol Pract. 2017; 5(4) :909–916. doi:https://doi.org/10.1016/j.jaip.2017.04.038.
   PubMed Web of Science ®Google Scholar
• Kim H , et al. Asthma biomarkers in the age of biologics. J Canadian Soc Allergy Clin Immunol . 2017;13:48.
   Google Scholar
• Bourdin A , Husereau D , Molinari N , et al. Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors: systematic review. Eur Respir J . 2018; 52(5):1801393. doi:https://doi.org/10.1183/13993003.01393-2018.
   PubMed Web of Science ®Google Scholar
• Albers FC , Müllerová H , Gunsoy NB , et al. Biologic treatment eligibility for real-world patients with severe asthma: the IDEAL study. J Asthma. 2018;55(2):152–160. doi:https://doi.org/10.1080/02770903.2017.1322611.
   PubMed Web of Science ®Google Scholar
• Bulathsinhala L , Eleangovan N , Heaney LG , et al. Development of the International Severe Asthma Registry (ISAR): a modified Delphi study. J Allergy Clin Immunol Pract . [Published online ahead of print, September 1, 2018; doi:https://doi.org/10.1016/j.jaip.2018.08.016.
   Google Scholar
• Canadian Network for Respiratory Care . [Réseau canadien pour les soins respiratory]. http://cnrchome.net/. Accessed November 11, 2018.
   Google Scholar